Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis.
DJ Speden, AI Calin, FJ Ring, AK Bhalla - The Journal of Rheumatology, 2002 - jrheum.org
OBJECTIVE: To assess bone mineral density (BMD) by dual energy x-ray absorptiometry
(DEXA) and calcaneal quantitative ultrasound (QUS) in a cohort of pre-and postmenopausal …
(DEXA) and calcaneal quantitative ultrasound (QUS) in a cohort of pre-and postmenopausal …
Effect of zoledronic acid and denosumab in patients with low back pain and modic change: a proof‐of‐principle trial
The aim of this study was to evaluate the effect of zoledronic acid (ZA) and denosumab on
low back pain (LBP) and Modic change (MC) over 6 months. Adults aged≥ 40 years with …
low back pain (LBP) and Modic change (MC) over 6 months. Adults aged≥ 40 years with …
Adalimumab in patients with vision-threatening uveitis: real-world clinical experience
TLTL Say, V Yang, JM Fingret, S Zagora… - BMJ open …, 2021 - bmjophth.bmj.com
Objectives Biologics are rapidly emerging as an effective vision saving addition to systemic
uveitis therapy. The aim of this multicentre retrospective study is to review the outcomes of a …
uveitis therapy. The aim of this multicentre retrospective study is to review the outcomes of a …
Outcomes from a Multi-disciplinary Uveitis Referral Clinic in Tasmania, Australia and adaptation during the COVID-19 pandemic
CA Ovens, V Yang, WB Yates, N Verma, D Speden… - 2021 - researchsquare.com
Background: Uveitis is one of the most common causes of visual impairment, accounting for
up to 25% of visual loss in the developing world and 10% in developed countries. There are …
up to 25% of visual loss in the developing world and 10% in developed countries. There are …
[PDF][PDF] Effect of zoledronic acid and denosumab in patients with low back pain and Modic change: a proof of principle trial 2
PO GDipSci, D Speden - figshare.utas.edu.au
Pan, F and Otahal, P and Speden, D and Winzenberg, TM and Jones, G, Effect of Zoledronic
Acid and Denosumab in patients with low back pain and modic change: A proof-of-principle …
Acid and Denosumab in patients with low back pain and modic change: A proof-of-principle …
Adalimumab therapy in patients with vision threatening uveitis
TLTL Say, V Yang, J Fingret, SL Zagora… - … & Visual Science, 2021 - iovs.arvojournals.org
Purpose: The aim of this multicentre retrospective study was to review the outcomes of a
large group of patients treated with systemic biologic therapy. Methods: Retrospective chart …
large group of patients treated with systemic biologic therapy. Methods: Retrospective chart …
[PDF][PDF] Clinical Trial Effect of zoledronic acid and denosumab in patients with low back pain and Modic change: a proof of principle trial
G Cai, PO GDipSci, D Speden - figshare.utas.edu.au
The aim of this study was to evaluate the effect of zoledronic acid (ZA) and denosumab on
low back pain (LBP) and Modic change (MC) over 6 months. Adults aged≥ 40 years with …
low back pain (LBP) and Modic change (MC) over 6 months. Adults aged≥ 40 years with …
[CITATION][C] THE NOVEL USE OF LONG-TERM HOME TOTAL PARENTERAL NUTRITION IN DIFFUSE SYSTEMIC SCLERODERMA WITH ASSOCIATED …
B Emma, T Malcolm, F Hilton… - INTERNAL …, 2016 - … ST, HOBOKEN 07030-5774, NJ USA